(MedPage Today) — Health news and commentary from around the Web, gathered by the MedPage Today staff.
Imprimis reports $2.5 million net loss in third quarter
Imprimis Pharmaceuticals reported a net loss of $2.5 million, or $0.27 per common share, in the third quarter, compared with a loss of $2.1 million, or $0.23 per common share, in the third quarter of last year, according to a press release.Total revenu…
Macular degeneration may be treatable with HIV drug
A new study conducted on mice suggests that already-approved drugs that have been used for 30 years to treat HIV could be re-purposed to treat age-related macular degeneration.
Blind Veterans UK calls for NHS healthcare professionals to signpost blind and vision impaired ex-Service men and women to its free services
Blind Veteran UK’s No One Alone campaign is calling for more to be done by NHS healthcare professionals to improve referral pathways to the charity, so that veterans are signposted to support as a…
Ocular Therapeutix to evaluate sustained-release travoprost for glaucoma, ocular hypertension
Ocular Therapeutix has begun enrolling the first subjects in a phase 2b clinical trial to evaluate the safety and efficacy of sustained-release travoprost, according to a press release.Sustained-release travoprost (OTX-TP) is being evaluated for the re…
Using video games to improve lazy eye, depth perception
Scientists have created video games that add an important element of fun to the repetitive training needed to improve vision in people – including adults – with a lazy eye and poor depth perception.